Last reviewed · How we verify
NCT05187312: ERDB
Registry for Advanced Endoscopy
trial testing Endoscopic retrograde Cholangio- pancreatography in Cholangiocarcinoma in 1,000 participants. Currently enrolling.
14 January 2032
Quick facts
| Lead sponsor | Region Stockholm |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 1,000 |
| Start date | 14 January 2022 |
| Primary completion | 14 January 2032 |
| Estimated completion | 14 January 2032 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Endoscopic retrograde Cholangio- pancreatography
- Endoscopic ultrasound
Conditions studied
- Cholangiocarcinoma — all drugs for Cholangiocarcinoma →
- Pancreatic Cancer — all drugs for Pancreatic Cancer →
- Sclerosing Cholangitis — all drugs for Sclerosing Cholangitis →
Sponsor
Region Stockholm — full company profile →
Who can join
18 and older, any sex, with Cholangiocarcinoma or Pancreatic Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Observational registry including endoscopic diagnostic and therapeutic interventions in the gastrointestinal tract
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05187312
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cholangiocarcinoma
Currently open trials in the same condition.
- NCT07486713 — Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies · Phase 4 · recruiting
- NCT07291947 — PULSAR Combined With Immunotherapy and Chemotherapy · Phase 1, PHASE2 · recruiting
- NCT07359586 — Laryngopharyngeal Injury After Endotracheal Intubation Under General Anesthesia · recruiting
- NCT07263217 — Mechanistic Study on the Protective and Regenerative Effects of Spirulina in Hepatectomy-Related Liver Injury · NA · recruiting
- NCT07155525 — Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas · Phase 3 · recruiting
Other Region Stockholm trials
Trials by the same sponsor.
- NCT06304363 — Braining - Evaluation of Acute Effects of Physical Exercise · NA · not yet recruiting
- NCT07089771 — Virtual Versus Dye-based Chromoendoscopy in Inflammatory Bowel Disease Surveillance Colonoscopy · NA · not yet recruiting
- NCT07503951 — Cognitive Behavior Therapy in Psychiatric Inpatient Care · NA · not yet recruiting
- NCT07434219 — A Group Based Psychoeducational Intervention for Partners of Child Sexual Abuse Material Offenders. · NA · not yet recruiting
- NCT07464730 — Postoperative High-flow Nasal Oxygenation After High-risk Surgery in the Frail Adult · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05187312 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Region Stockholm
- Last refreshed: 12 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05187312.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing